Peer Review History
| Original SubmissionOctober 7, 2025 |
|---|
|
Dear Dr. Raza, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 10 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Md. Kamrujjaman, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 3. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 4. We note that your Data Availability Statement is currently as follows: “All relevant data are within the manuscript and its Supporting Information files.” Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 6. We notice that your supplementary figures are uploaded with the file type 'Figure'. Please amend the file type to 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list. 7. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 2 in your text; if accepted, production will need this reference to link the reader to the Table. 8. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: No Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: I Don't Know Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: The authors should rewrite the manuscript to address all noted concerns, verify all mathematical derivations and results, and resubmit only after thorough revision. Even I am not sure whether it's possible to overcome, especially the theoretical analysis. Due to the pervasive issues in clarity, mathematical correctness, and presentation, the manuscript requires substantial revision. Reviewer #2: This manuscript presents a comprehensive and mathematically rigorous analysis of a stochastic delayed differential equation model for Maize Streak Virus (MSV) dynamics. The work is well-structured, moving from a deterministic formulation to a complex stochastic model with time delays. The analytical proofs for positivity, boundedness, equilibrium stability, and disease extinction are thorough. A significant strength of the paper is the detailed comparison of various stochastic numerical methods (Euler-Maruyama, Runge-Kutta, NSFD), with a clear demonstration of the advantages of the stochastic Non-Standard Finite Difference (NSFD) scheme in terms of stability and step-size independence. The discussion on the impact of time delay (τ) on the basic reproduction number (R₀) and disease dynamics is particularly insightful and valuable for understanding control strategies. The manuscript is suitable for publication in PLOS ONE after the authors address the following points, which primarily aim to clarify methodology and strengthen the discussion. 1. Model Parameterization and Validation: The parameters in Table 2 are listed as "Fitted" or "Estimated." Could you please provide more detail on the data source and the procedure used for this parameter estimation or fitting? Furthermore, how were the values for the stochastic noise intensities (σ₁ to σ₅) chosen for the simulations in Section 8? 2, Clarification of Stochastic Formulations: The manuscript presents two different stochastic formulations (Phase 1 in Eqs. 9-10 and Phase 2 in Eqs. 11-15). Phase 1 uses a complex diffusion matrix derived from transition probabilities, while Phase 2 uses a simpler, more common linear multiplicative noise. Could you clarify the relationship between these two approaches and justify why the analysis and numerical simulations primarily focus on the model from Phase 2? 3. "Bioinformatics" in the Title and Scope: The term "Bioinformatics" is prominently featured in the title, yet the manuscript is predominantly a mathematical and computational modeling study. Could you elaborate on the specific bioinformatics analyses performed (e.g., sequence data analysis, phylogenetic analysis) or clarify the usage of the term to align better with the paper's core content, perhaps focusing on "computational biology"? 4. Numerical Comparison Metrics: The conclusion states that the stochastic NSFD approach is the "most accurate, productive, and efficient." To strengthen this claim, could you provide quantitative metrics for this comparison, such as computational time (CPU time), mean squared error compared to a benchmark solution, or stability region analyses for the different methods? 5. Biological Interpretation of Delay (τ): The time delay τ is a critical component of the model. While its mathematical impact is well-demonstrated, could you provide a more detailed biological interpretation? What specific biological processes (e.g., the latent period in the insect vector, the incubation period within the plant, or a delay in implementing control measures) is this delay intended to represent? 6. Impact of Insecticide Treatment: The parameter γ represents the efficacy of the insecticide treatment. The analysis shows its role in the reproduction number R₀, but could you discuss the simulation results that specifically illustrate the impact of varying γ on the infected plant population? This would provide direct insights into the effectiveness of insecticide-based control strategies. Suggested References for Inclusion The authors are also requested to consider citing the following recent papers, which demonstrate advanced numerical techniques for solving fractional and stochastic differential equations. These references would provide a broader context for the computational methods used in this manuscript and highlight the applicability of such schemes in complex modeling scenarios. For advanced collocation methods: 1. Raza, A., et al. "Collocation method with Morgan-Voyce polynomials to solve the time fractional long memory Black-Scholes model with jump process." Scientific Reports (2024). This work showcases a high-precision numerical technique for financial models with memory and jumps, which is methodologically relevant to the stochastic schemes discussed here. For enhanced numerical solutions of fractional dynamics: 2. Raza, A., et al. "Enhanced numerical solution for time fractional Kuramoto–Sivashinsky dynamics via shifted companion Morgan–Voyce polynomials." Scientific Reports (2024). This paper presents an efficient spectral method for nonlinear fractional PDEs, underscoring the importance of robust numerical solvers in computational biology and other fields. Reviewer #3: Please take a look at the attached detailed review document for full comments and recommendations. I have addressed each evaluation point thoroughly in the attached file. Going through those points will be enough. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Nuzhat Nuari Khan Rivu ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 1 |
|
Computational Analysis of Stochastic Delay Dynamics in Maize Streak Virus PONE-D-25-54354R1 Dear Dr. Raza, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Md. Kamrujjaman, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: After a thorough evaluation of the revised manuscript, I am satisfied that the authors have carefully and comprehensively addressed all the comments and suggestions raised during the initial round of review. The revisions have significantly improved the clarity, organization, and scientific rigor of the manuscript. All methodological issues have been appropriately clarified, the presentation of results has been enhanced, and the discussion has been strengthened to reflect the study’s contributions more effectively. The manuscript now demonstrates coherence, proper referencing, and adherence to the journal’s formatting and academic standards. Given that the authors have fulfilled all the review criteria and the manuscript now meets the required quality for scholarly publication, I am pleased to recommend it for publication. Reviewer #2: (No Response) Reviewer #3: The revised manuscript addresses previous comments effectively, and the technical presentation is now clear and well-organized. Everything appears satisfactory. However, I recommend that the authors make their simulation codes publicly available (for example, by uploading them to a GitHub repository). This will enhance transparency and allow other researchers to reproduce or extend the study in the future. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Nuzhat Nuari Khan Rivu **********
|
| Formally Accepted |
|
PONE-D-25-54354R1 PLOS ONE Dear Dr. Raza, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Md. Kamrujjaman Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .